Woowa Brothers reported 2020 sales of 1.1 trillion won, up 94.4 percent from the previous year, driven by a sharp increase in online orders amid the pandemic.
However, Woowa Brothers, the operator of South Korea’s top food delivery app Baedal Minjok or Baemin, posted an operating loss of 11.2 billion won due to higher marketing and promotional costs. The shortfall was narrowed by 69.2 percent from 2019.
Baemin is South Korea’s largest food delivery service firm with a 63.2 percent market share, trailed by Yogiyo at 29 percent and Coupang Eats at 6.3 percent. Industry watchers expect competition among food delivery services to heat up this year.
According to the Korea Fair Trade Commission, the domestic food delivery market reached 23 trillion won in 2020, up 53 percent from 15 trillion won two years earlier.
Woowa recently announced a collaboration with Hyundai Motor Co. to develop delivery robots that could travel through various building structures and be equipped with a payment service.
The company aims to enter the Southeast Asian market this year. It is in the process of selling a controlling stake in Baemin to Germany’s Delivery Hero SE.
Woowa founder and Chief Executive Kim Bong-jin launched the Baemin service in 2010 with 30 million won in capital.


Baidu Shares Sink to One-Year Low as Ad Weakness Overshadows AI Growth
SK Hynix Shares Surge on Record $28.6 Billion Buyback
Goldman Sachs Names 9 Top Japanese Semiconductor and Electronics Stocks
Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised
Shein Targets $26B-$27B Valuation for Hong Kong IPO
Hermès Stock Downgraded by RBC as Luxury Growth Premium Narrows
Coty Revenue Beats Estimates as Beauty Demand Holds Firm
Lockheed Martin Secures $153.5 Million in U.S. Defense Contracts
Standard Chartered Expands Hedge Fund Access for Wealth Clients
Google to Buy Spirit Airlines Business Data for $10 Million to Train AI
OpenAI Revenue Rises 18% in Q2 as Losses Widen and Anthropic Surges Ahead
OpenAI Tightens AI Safety Monitoring After Security Incidents
Schott Pharma Stock Rises as Barclays Upgrades Rating on Growth Outlook
Samsung Eyes $72 Billion Shareholder Return Plan as AI Chip Boom Fuels Profits
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
REPAY Stock Rises After Visa Platform Connect Collaboration
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case 



